InternationalUSRemember you can easily switch between MIP US and MIP International at any time

European Commission claims pharma competition success

Legal Media Group


The proportion of problematic patent settlements in the pharmaceutical industry has fallen, even though the number of settlements has grown, according to the European Commission

In a statement published on January 31, the Commission said that its third annual survey had found that 11% of antitrust settlements were potentially problematic from an antitrust point of view, compared to 21% when the pharmaceutical sector enquiry was conducted in 2008 to 2009.

That came as the total number of settlements reached 120 in 2011,...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

RT @OAMITWEETS: Come & see #OHIM at #INTA15! Here's a detailled timetable of all our workshops at Stand 1528 http://t.co/ddF1obvNnd http://…

Apr 21 2015 11:41 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @michaelhorak: RT WIPO "RT UNGeneva: Get up, stand up - for music! Today WIPO in Geneva: #WorldIPDay debate on the future of musi… http:…

Apr 21 2015 11:37 ·  reply ·  retweet ·  favourite
ManagingIP profile

It's a big day for EU trademark reform with potentially decisive discussions in Brussels ($) http://t.co/4pMwA86cFX http://t.co/X8u8m0ou5P

Apr 21 2015 11:35 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


AIPLA Daily Report 2014

Read this year's AIPLA Daily Report - published daily by Managing IP direct from the AIPLA Annual Meeting in Washington DC


null null null

April 2015

Zynga’s IP game

The gaming company’s IP lawyer Renee Lawson tells Emma Barraclough about the move from partner to start-up, why the company listens to its lawyers, and the ups and downs of cross-border litigation



Most read articles

Supplements